Analysis

With Premier Horgan's stated goal of restoring 'legendary' status to provincial product, there should be more money where his mouth is

Shares of Hexo slipped another 5% after reporting a third-quarter net loss of $19.5 million

The bulk value category is trending up as legal players compete with Canada's still-thriving unregulated market

Best way to reduce police violence is to scale back funding and amount of responsibility police have, says criminology prof

Aaron Salz with Stoic Advisory sees a brutal year ahead for Canadian cannabis companies but brighter horizons in 2021

Research, therapeutic and medical drug development and investment can all flourish under pre-existing legal pathways, experts say

With production costs as low as $0.10 a gram in Canada, some analysts predict outdoor cultivation will disrupt legal weed

Cannabis lawyer Ranjeev Dhillon remains optimistic for the longevity of the industry despite the pandemic-related market meltdown

The recent COVID-19-related sales bump won't last as demand for cannabis isn't as inelastic during a recession as some think, Jerome Hass of Lightwater Partners says

Analysis: Business professor says weed companies have to make tough decisions to survive the oncoming recession, as his did in the dot-com era